Scrip Asks… What Does 2020 Hold For Biopharma? Part 4: The Patient
Pharma Is Getting More Personal
Executive Summary
From the general to the particular: drug developers are increasingly tailoring therapies to individuals. Driven by important advances in understanding biology as well as new tools to harness big data, industry participants expect significant progress in biopharma’s approach to the patient.